What Does C. diff NAAT Positive but Toxin Negative Mean?
A positive NAAT with negative toxin indicates detection of toxigenic Clostridioides difficile bacteria (or its toxin genes) in the stool, but without detectable free toxin—this represents either colonization, early/low-level infection, or resolving disease, and requires clinical correlation to determine if treatment is warranted.
Understanding the Test Results
The discordant result (NAAT+/toxin-) occurs because:
- NAAT detects the presence of toxin genes (tcdB) in C. difficile bacteria, indicating toxigenic strains are present
- Toxin EIA detects actual free toxin protein in stool, which correlates more closely with active disease
- The gap between these results reflects that having toxigenic bacteria doesn't always mean active toxin production causing disease 1
Clinical Significance & Outcomes
NAAT+/toxin- patients have significantly different outcomes compared to NAAT+/toxin+ patients:
- Lower recurrence rates: 11-14% vs 19.8% in toxin-positive patients (RD 7.65%) 2, 3
- Lower severe CDI rates: Significantly reduced compared to toxin-positive cases 2
- Similar mortality: No significant difference in 30-day all-cause mortality (6.7% vs 8.4%) or CDI-related complications 2, 3
- Only 5% progress to toxin positivity overall, though risk increases substantially (15-fold) with subsequent antibiotic exposure 4
Treatment Decision Algorithm
Most NAAT+/toxin- patients (70-78%) receive CDI treatment in real-world practice 5, 6. The decision should be based on:
Treat if patient has:
- ≥3 unformed stools in ≤24 hours with recent antibiotic exposure
- White blood cell count ≥15,000/μL
- Clinical signs of severe disease (fever, abdominal pain, hemodynamic instability)
- High clinical suspicion despite negative toxin 1, 5
Consider withholding treatment if:
- Minimal diarrhea or multifactorial diarrhea (chemotherapy, laxatives, tube feeds)
- No recent antibiotic exposure
- Alternative explanation for symptoms is clear
- Patient is clinically stable
Key clinical predictors of benefit from treatment:
Among NAAT+/toxin- patients, treatment was associated with reduced 30-day mortality (5.0% treated vs 12.7% untreated, RD -7.45%) but not reduced recurrence 3. Factors predicting treatment benefit include leukocytosis ≥15,000/μL and ≥3 unformed stools for ≥1 day 5.
Important Caveats
The toxin result should NOT be the sole determinant of treatment decisions 2. Key pitfalls to avoid:
- Don't assume colonization: While NAAT+/toxin- may represent colonization, these patients still have comparable rates of CDI-related complications and mortality to toxin-positive patients 2
- Don't reflexively withhold treatment: 73% of NAAT+/toxin- patients are classified as having probable or possible CDI upon clinical review 6
- Don't repeat testing within 7 days: Diagnostic yield is only ~2% and risks false-positive results 1
- Don't test asymptomatic patients: This only detects colonization 1
The Diagnostic Accuracy Context
The 2-step algorithm (GDH or NAAT followed by toxin) was designed to improve specificity over NAAT alone 1, 7. However:
- NAAT alone: 94% sensitivity, 99% specificity for detecting toxigenic C. difficile 1
- Toxin EIA limitations: Only 48-73% sensitivity, though highly specific for active toxin production 1, 8
- Clinical diagnosis remains imperfect: Even with optimal testing, correlation with clinical presentation is essential 1
The bottom line: NAAT+/toxin- results require clinical judgment. Base treatment decisions on the complete clinical picture—diarrhea frequency, antibiotic exposure, leukocytosis, and disease severity—not the toxin result alone 2, 5.